Oxford Immunotec

📍 Abingdon, United Kingdom🗓 Founded 2001👥 287 employees💰 Last funded Dec 2014
Biotechnology Research🌐 oxfordimmunotec.com
Website LinkedIn
Oxford Immunotec is a global, high-growth diagnostics company focused on developing and commercializing proprietary assays for immunology and infectious disease. The Company's T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company is headquartered near Oxford, U.K. and in Marlborough, MA. http://www.oxfordimmunotec.com/north-america/wp-content/uploads/sites/2/Disclaimer-V2.pdf
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2001
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Germany
1
United States
1
Frequently asked questions
Who invested in Oxford Immunotec?
Oxford Immunotec has 2 investors on record on gritt.io and 1 late-stage investors.
When did Oxford Immunotec last raise funding?
The most recent investment in Oxford Immunotec recorded on gritt.io was in December 2014.
When was Oxford Immunotec founded?
Oxford Immunotec was founded in 2001.
What industry is Oxford Immunotec in?
Oxford Immunotec operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Oxford Immunotec based?
Oxford Immunotec is headquartered in Abingdon, United Kingdom.